Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
2 Patients with a diagnosis of malignancy established by pathologic review of H\&E staining of tumor biopsy or tumor resection without definitive determination of tissue of origin as assessed by the PI. Samples must have been obtained within three months of enrollment, or the patient must still be under active evaluation for tissue of origin at the time of enrollment. There are no limitations on prior therapy and time from last prior therapy.
You may not be if
2 There are no exclusion requirements due to co-morbid disease or incurrent illness, as needed.
3 Pregnancy or nursing participants will not be excluded from the study.
4 Patients with a diagnosis of leukemia including acute myelogenous leukemia, acute lymphocytic leukemia, hairy cell leukemia, chronic myelogenous leukemia and chronic lymphocytic leukemia are excluded from enrollment on this study. The TOO test does not cover these diagnoses.
Clareo Health | Evaluation of Pathwork Tissue of Origin (TOO) Test for Human Malignancies
